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Abstract
Staphylococcus aureus is a dangerous human pathogen and a leading cause of both
nosocomial and community-associated infections. Infection by S. aureus is a growing
health concern due to the emergence of antibiotic resistance and the capability to form
robust biofilms. Major constituents of the biofilm extracellular matrix are demonstrated
to be released via controlled autolysis of a subpopulation of the biofilm. As indicated in
past studies, the programmed cell death (PCD) of S. aureus grown in a biofilm
microenvironment is potentiated by the buildup of acetate, a byproduct of glucose
metabolism, which causes cytoplasmic acidification. Furthermore, it has been shown that
the use of antibiotics in low doses stimulates biofilm formation by inducing autolysis.
Our lab has recently shown that the deletion of the msaABCR operon in S. aureus causes
a decrease of biofilm thickness and an increase of dead cell biomass in the biofilm
relative to wild-type (WT). However, the precise mechanism is still largely unknown. I
hypothesized that msaABCR plays an important role in antibiotic- and glucose-induced
biofilm formation by regulating cell death in S. aureus. To investigate this, I performed
biofilm assays in a msaABCR mutant with the addition of vancomycin. I also performed
late-stationary phase survival assays and measured the rate of acetate production in
excess glucose medium. Indeed, the results show that vancomycin is not able to induce
biofilm formation in the msaABCR mutant and that the mutant exhibits an increased rate
of cell death relative to WT under excess glucose conditions. Furthermore, acetate
production was increased in the mutant with excess glucose relative to WT. These results
suggest uncontrolled weak acid-dependent cell death in the msaABCR mutant.
Keywords: Staphylococcus aureus; biofilm; msaABCR operon; cell death; acetate

iv

Dedication
To Matthew, Gracie, and Blair
Without your love, support, and encouragement, this would not have been possible. I am
immensely grateful to you all for everything that you do.

v

Acknowledgements
First, I would like to express my gratitude to my honors advisor, Dr. Mohamed O.
Elasri for giving me the opportunity to join his laboratory. Without his support and
mentorship, this project would not have been possible. I am also very grateful to Dr.
Sahukhal Gyan, who has always shown me great kindness and encouraged me to
participate in several scientific conferences, and to graduate student Bibek G.C. I am
incredibly thankful for Bibek’s unending patience and direct guidance with this research
project, from teaching me new lab techniques to assisting me with the writing process. To
graduate student Shanti Pandey and everyone in the lab, I would like to extend the
warmest thank you. Their relentless work ethic, kindness, positivity and patience has
inspired me daily. I will always cherish our friendship and the invaluable lessons that
they all have taught me.
This work was supported by the Mississippi INBRE, an Institutional
Development Award (IDeA) from the National Institute of General Medical Sciences
under grant number P20GM103476.

vi

Table of Contents
List of Figures

ix

List of Abbreviations

x

Chapter I: Introduction

1

Chapter II: Literature Review

4

Staphylococcus aureus: A brief background

4

Genetic virulence regulation of S. aureus

6

S. aureus biofilm

8

Antibiotic-mediated biofilm formation

11

Mechanisms and regulation of autolysis in biofilm

12

Role of carbon-overflow metabolism in autolysis and biofilm formation

14

Introduction to the msaABCR operon

16

Hypothesis and aim of study

20

Chapter III: Materials and Methods

22

Bacterial strains and growth conditions

22

Media preparation

22

Bacterial growth normalization of liquid cultures

23

Biofilm assays

23

Cell death assays

24

Measurement of acetate production

25

Data analysis

25

vii

Chapter IV: Results

26

Excess glucose and vancomycin cannot induce biofilm formation in
the msaABCR deletion mutant

26

The msaABCR operon represses unregulated cell death in biofilm condition

27

Deletion of the msaABCR operon causes an increase in acetate production

30

Increased cell death in the msaABCR deletion mutant is due to weak acid
intracellular acidification

32

Chapter V: Discussion

36

References

40

viii

List of Figures
Figure 1. Schematic of various infections caused by S. aureus

5

Figure 2. Stages of S. aureus biofilm development

10

Figure 3. Proposed regulatory network of cidABC and lrgAB operons

13

Figure 4. Regulatory role of CidR in production of acetate and mechanism of
cell death

16

Figure 5. Proposed regulatory role of the msaABCR operon

17

Figure 6. CLSM images of biofilm

18

Figure 7. CLSM image analysis of biofilm

19

Figure 8. Biofilm formation of USA300 LAC wild-type, msaABCR deletion mutant,
and complementation strains

27

Figure 9. Stationary phase survival of USA300 LAC without excess glucose

28

Figure 10. Stationary phase survival of USA300 LAC with excess glucose

29

Figure 11. Stationary phase survival of UAMS-1 with excess glucose

30

Figure 12. Acetate production in USA300 LAC, msaABCR deletion mutant and
complementation

31

Figure 13. Stationary phase survival of USA300 LAC grown in excess glucose
conditions with added MOPS buffer

33

Figure 14. Stationary phase survival of UAMS-1 grown in excess glucose conditions with
added MOPS buffer

34

Figure 15. Biofilm formation of USA300 LAC with addition of excess glucose and
MOPS buffer

35

ix

List of Abbreviations
Acetyl-CoA

acetyl-coenzyme A

AckA

acetate kinase

agr

accessory gene regulator

AIP

auto-inducing peptide

AlsSD

-acetolactate synthase/decarboxylase

CA-MRSA

community-acquired methicillin-resistant Staphylococcus aureus

CidC

pyruvate oxidase

CLSM

confocal laser scanning microscopy

cna

collagen-binding protein

CFU

colony-forming unit

eDNA

extracellular DNA

EPS

extracellular polymeric substances

fnbA

fibrinogen-binding protein

HIV/AIDS

human immunodeficiency virus infection/acquired immune
deficiency syndrome

ica

intercellular adhesion

MOPS

morpholinepropanesulfonic acid

MRSA

methicillin-resistant Staphylococcus aureus

msa

modulator of sarA

MSCRAMM

microbial surface components recognizing adhesive matrix
molecules

MSSA

methicillin-sensitive S. aureus

x

OD

optical density

QRT-PCR

real-time quantitative polymerase chain reaction

PCD

programmed cell death

PCR

polymerase chain reaction

PDH

pyruvate dehydrogenase

PIA

polysaccharide intercellular adhesion

PNAG

poly-N-glucosamine

PTA

phosphotransacetylase

qPCR

quantitative polymerase chain reaction

ROS

reactive oxygen species

sarA

staphylococcal regulator A

S. aureus

Staphylococcus aureus

sub-MIC

subminimal inhibitory concentration

TCA

tricarboxylic acid

TSA

tryptic soy agar

TSB

tryptic soy broth

tst

toxic shock syndrome toxin-1

VRSA

vancomycin-resistant Staphylococcus aureus

WT

wild-type

xi

Chapter I: Introduction
Staphylococcus aureus is a dangerous and important opportunistic human
pathogen and is the leading cause of nosocomial and community-associated infections (8,
15, 31). These infections caused by S. aureus can affect almost every organ system in the
body and are associated with high morbidity and mortality rates (3, 20). Due to its
capability to form robust, adherent multicellular communities called biofilms, S. aureus
can survive on both biotic and abiotic surfaces. In addition to aiding the attachment and
colonization on multiple surfaces, biofilms also allow S. aureus to sufficiently evade host
immune system defenses and tolerate unfavorable environmental stressors, including
chemical detergents and disinfectants (2, 9, 11, 24, 27, 29, 31). This characteristic is
particularly concerning in regard to indwelling medical devices and surgical hardware,
such as catheters. In fact, S. aureus is one of the bacterial most frequently associated with
post-surgical and catheter-related infections (3, 8, 15, 16, 37). Treatment of S. aureus
infections has become particularly challenging because of the increasing prevalence of
antibiotic-resistant strains, such as methicillin-resistant S. aureus (MRSA) and
vancomycin-resistant S. aureus (VRSA). Biofilm formation has been shown to be linked
to antibiotic resistance, further increasing the overall virulence and the success of S.
aureus to withstand antibiotic treatments (23). Furthermore, when antibiotics are
administered at low levels, this triggers a stress response and further induces biofilm
formation in S. aureus (23, 30). To tackle this urgent issue, research is imperative to
identify new strategies for inhibiting the production of biofilms and the resistance to
antibiotics.
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The process of biofilm production in S. aureus is controlled by a remarkably
complex regulatory network. So far, past research has identified several important
transcriptional regulators, such as staphylococcal accessory regulator A (sarA) and
accessory gene regulator (agr), as well as gene operons, such as cidABC, lrgAB, and
alsSD (3, 6, 8, 21, 25, 31, 32, 35, 36, 38). One of the many global regulators and the main
focus of this study, the msaABCR operon, was identified and characterized in our lab (4,
27). In past research, the msaABCR operon has been indicated to be involved in the
regulation of virulence factors, antibiotic resistance, and development of biofilms (5, 26,
28, 30, 31, 32). However, much is still unknown about the precise regulatory mechanism
of msaABCR. Notably, the deletion of the msaABCR operon in a recent study yielded an
increase in cell autolysis and the production of a defective biofilm with decreased
thickness and biomass (26). It is suggested that the defective biofilm could be a result of
uncontrolled cell death, but the precise mechanism underlying this result is still not fully
understood.
The necessary constituents of the biofilm extracellular matrix have been shown to
be released as a result of controlled cell death of a subpopulation of the biofilm (25, 35,
38). This process has been indicated to share hallmark characteristics with eukaryotic
programmed cell death (PCD) and is highly regulated in S. aureus (35). Recent studies
have shown that this process is potentiated by acetate accumulation in the media under
low pH, leading to cytoplasmic acidification and activation of cell death (25, 35, 38).
Several genetic regulators are shown to be involved in the homeostatic balance between
cellular growth and replication and cell autolysis, ensuring proper biomass and adequate
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structural stability of the biofilm (25, 35, 38). However, disruptions to this balance that
trigger an excess of cell death will ultimately inhibit the maturation of the biofilm.
Based on these findings, I predicted that an uncontrolled accumulation of acetate
from overflow metabolism was responsible for the observed increase of autolysis and
defective biofilm formation. By assessing the cell viability, biofilm formation, and
acetate formation of the msaABCR mutant, I aimed to elucidate the role of msaABCR
during controlled cell death and glucose- and antibiotic-induced biofilm formation. This
work, in addition to other similar studies, is critical for understanding how S. aureus
regulates the production of biofilms and ultimately causes chronic infections.
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Chapter II: Literature Review
Staphylococcus aureus: A brief background.
Staphylococcus aureus is a mesophilic, Gram-positive coccus bacterium and an
important, opportunistic pathogen in humans (31). In a significant proportion of healthy
individuals, an approximate 25%-30%, S. aureus commonly exists as a commensal
member of the normal microflora and asymptomatically colonizes the nares, pharynx,
and skin (3, 8, 31, 34). Staphylococcus aureus is also a leading cause of nosocomial and
community-associated infections as well as foodborne intoxications (8, 15, 31). These S.
aureus infections are commonly associated with implanted or indwelling medical devices
and immunocompromised individuals; however, the incidence of infection is high in both
hospital and community settings (3, 8). Following its entry into the body, typically
through a breach in the skin, S. aureus can spread via the bloodstream and infect various
tissues and organs (3) (Fig. 1). The severity of these infections ranges from minor,
superficial skin lesions to chronic, life-threatening diseases such as osteomyelitis,
endocarditis, and toxic shock syndrome (3, 5, 31).
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Figure 1. Schematic of various infections caused by S. aureus. This bacterium can
cause a myriad of infections across multiple organ systems, such as the respiratory
system, central nervous system, cardiovascular system, skeletal system, digestive system,
and integumentary system (18).

In recent years, S. aureus infections have become exceptionally challenging to
treat due to the emergence of several antimicrobial drug-resistant strains, such as
methicillin-resistant S. aureus (MRSA) (2, 8, 21, 23, 26, 30, 31). Since the 1990s, the
number of MRSA strains has significantly increased in prevalence, accounting for onethird of the total S. aureus infections worldwide (30). Further complicating treatment of
infections, there has also been a recent rise in S. aureus strains resistant to vancomycin, a
glycopeptide antibiotic that was widely used by health care officials to treat MRSA
infections (8, 30). The ability of S. aureus to resist antibiotic treatments, adapt to distinct
5

environments, and cause of a myriad of diseases makes it a particularly dangerous and
important human pathogen. In fact, the number of deaths associated with S. aureus
infections has recently surpassed that of HIV/AIDS patients in the United States (37).
The capability of S. aureus to cause this impressive array of infections in various
tissues is considerably reliant on its arsenal of virulence factors. Notably, these virulence
factors include enterotoxins, capsular polysaccharides, surface-associated proteins,
degradative enzymes, and biofilm production (5, 11, 29, 32). The effective, coordinated
expression of these virulence factors requires an extraordinarily complex, multifaceted
system in S. aureus and is carefully controlled by several genetic regulators (5, 8). The
following sections delve into the basic understanding of this complicated regulatory
network. As the precise mechanism is still largely unknown, ongoing investigation of the
genetic virulence regulation in S. aureus is paramount in preventing infection and
developing novel, alternative treatments in the future.

Genetic virulence regulation of S. aureus.
As briefly mentioned an important contributor to the capability of S. aureus to
infect several distinct types of tissues is its ability to successfully adapt to the changes in
host microenvironments and nutrient availability. To accomplish this adaptation, S.
aureus employs numerous genetic regulators that coordinate the release of the
appropriate virulence factors according to the current state of its external environment (3,
8, 31, 32). Some of these regulators include loci agr, sarA, arlRS, sarH1 (sarS), lysSR,
sae, sigB, rot, and 1E3 (3, 21). Common signals known to trigger regulatory responses
include fluctuations in the pH, levels of carbon dioxide, cell density, and concentration of
autoinducing peptides (AIPs) (3, 8, 20). Two well-studied global regulators have been
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consistently demonstrated in numerous studies to play fundamental roles in virulence
regulation of S. aureus: the accessory gene regulator (agr) and staphylococcal accessory
regulator A (sarA) (3, 5, 6, 8, 13, 20, 21, 23, 28, 29, 31, 32).
The agr operon directly regulates virulence genes via a two-component system
that utilizes quorum sensing to recognize and respond to shifts in cell density (6, 8, 13,
20, 27, 32). When the cell density is high, the Agr system increases the production of
AIPs, which in sufficient amounts activate and increase the transcription of several other
virulence factor genes involved in invasive infection (20, 32). This consequently triggers
an increase in secreted virulence factors and exoproteins such as toxins and degradative
enzymes (13, 20, 21, 32, 36). Conversely, the Agr system decreases the expression of
virulence factors involved in adhesion, colonization, and biofilm formation (13, 20, 21,
32, 36). Thus, there is an observed decrease in the production of surface adhesins and cell
wall-associated proteins; these virulence factors are instead produced predominantly
during the post-exponential growth phases (1, 21, 32).
The sarA operon, which was initially described by Cheung et al. (10), has been
implicated in being an activator of the agr operon. In addition, several studies have
shown the major protein product of sarA, SarA, to be an agr-independent regulator of
transcription of other virulence genes (3, 21, 31). Specifically, the SarA protein has been
demonstrated in many studies to down-regulate or repress the expression of collagenbinding protein (cna), extracellular proteases (ssp, aur, and scp), and protein A (spa) (13,
20, 21, 32). SarA has also been shown to up-regulate or activate the expression of hla,
toxic shock syndrome toxin-1 (tst) and fibrinogen-binding protein A (fnbA) (3, 21, 32).
In addition to the agr and sarA operons, several recently identified regulators have been
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indicated to be involved in the virulence regulation of S. aureus but solicit further
characterization and study. One of these global regulators – and the main focus of this
work – is the operon msaABCR.

S. aureus biofilm.
One of the major virulence factors of S. aureus that this work focuses on
specifically is the biofilm. A biofilm is a diverse, sessile community of several species of
bacteria embedded in a matrix of extracellular polymeric substances (EPS) (2, 24, 31).
This thick, motley biomaterial matrix is the structure that allows the bacteria to adhere to
almost any surface – living or non-living – in a solid-liquid interface (2, 24). The EPS can
be acquired from the environment but are more commonly produced by the bacteria
living within the biofilm (2); this EPS matrix is comprised of proteins, lipids,
polysaccharides and extracellular nucleic acids (2, 25, 26, 27, 31, 32). The biofilm that is
produced by S. aureus is highly organized and characterized by its dense, threedimensional mushroom shape (11, 24, 27, 29). Biofilm formation of S. aureus can be
divided into three stages: attachment, accumulation, and detachment (12, 31) (Fig. 2).
Primary attachment to surfaces is mediated by the production of adhesive cell wall
proteins, such as microbial surface components recognizing adhesive matrix molecules
(MSCRAMMs). The MSCRAMMs help tether S. aureus cells in the biofilm to the host
proteins (15, 27, 36) Then, S. aureus cells adhere to the extracellular matrix and form a
thick, multilayered community of cells. After the accumulation of the biofilm, cells then
gradually detach from the biofilm and migrate to additional areas for subsequent
colonization to occur (12, 31). The biofilms produced by S. aureus are frequently
classified as either ica-dependent or ica-independent biofilms (12). The intercellular
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adhesion (ica) operon codes for enzymatic membrane proteins Ica, IcaD, and IcaC and
extracellular protein IcaB (33, 39). The activation of the ica operon is responsible for the
production of the polysaccharide intercellular adhesion (PIA), also known as poly-Nglucosamine (PNAG), a major polysaccharide component of the biofilm extracellular
matrix (12, 15, 33, 39).
Ica-dependent biofilm formation is the most common method associated with
methicillin-sensitive S. aureus (MSSA) biofilms, but PIA production has been shown to
not be essential for methicillin-resistant S. aureus (MRSA) strains (22). In addition,
special MSCRAMMs called fibronectin-binding proteins (FnBPs) and the major
autolysin, Atl, were identified to be required in MRSA biofilm production but not
associated with PIA production or ica-dependent biofilm formation (15, 16, 22). Several
studies have shown that cell lysis mediated by Atl is required for the release of
extracellular DNA (eDNA) (22). In addition to eDNA, other cytoplasmic proteins
required for the formation of the biofilm matrix of MRSA biofilms have been indicated to
be released by autolysis during the stationary phase of growth (15, 22). While MSSA
biofilm production has been shown to be induced by NaCl, MRSA biofilm production is
induced by the addition of glucose, which consequently leads to the acidification of the
culture growth medium (22).
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Figure 2. Stages of S. aureus biofilm development. The process of biofilm
development is as follows: (A) initial attachment of planktonic bacteria to surface, (B)
accumulation of biofilm, and (C) detachment and dispersion of cells from biofilm (19).

In addition to allowing the bacteria to attach to various abiotic and biotic surfaces,
the biofilm also provides protection to S. aureus cells against the host immune defenses,
antimicrobial drugs, and other environmental stressors (2, 9, 11, 24, 27, 29, 31). This
feature of biofilms has become a growing concern in health care because it enables S.
aureus to cause chronic infections that are highly resistant to the typical types and
dosages of antibiotics that would be used for treatment (35). In fact, studies show that S.
aureus biofilms are capable of withstanding 10 to 10,000 fold higher concentrations of
antibiotics necessary to inhibit planktonic, or free-floating, S. aureus (33). These
problematic treatment barriers are commonly seen in the case of medically implanted
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devices, but they also concern the food production industry. Biofilm production presents
considerable risk to food contamination, as these structures support the survival of S.
aureus on food preparation and contact surfaces and offer protection against stressors,
including disinfectants, sanitizers, and antibiotics (2, 11). In this way, biofilm production
of S. aureus contributes to a substantial financial burden and significant economic losses
in the fields of health care and food handling industry. Therefore, there is a growing need
for novel, alternative therapeutics in efforts to target and prevent S. aureus biofilm
formation.

Antibiotic-mediated biofilm formation.
Studies have shown that the administration of antibiotics in subminimum
inhibitory concentrations (sub-MICs) can stimulate biofilm formation of S. aureus (14,
15, 16, 17, 23, 30). In fact, this is observed commonly in all bacteria and is understood to
be a global response to environmental stressors. At sub-MICs, cell wall-active -Lactam
antibiotics, such as methicillin, have been demonstrated to increase S. aureus biofilm
formation in vitro as much as four-fold (17). Findings from other studies suggest that this
antibiotic-induced biofilm formation is mediated by eDNA release, resulting from
increased cell lysis mediated by cidA (15, 16). Hsu et al. (16) recently demonstrated that
the sub-MIC addition of vancomycin and supplementation of glucose induces biofilm
formation in vitro. Additionally, in an in vivo study of mice infected with vancomycinresistant S. aureus, Hsu et al. (16) demonstrated that biofilm production was enhanced
during treatment with vancomycin in diabetic mice relative to non-diabetic mice. Since
vancomycin is one of the most common antibiotics used to treat MRSA infections, this
presents a very complicated issue for health care (15, 16, 22).
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Mechanisms and regulation of autolysis in biofilm.
Although seemingly counterintuitive, cell death via autolysis is a necessary step
for biofilm development in S. aureus. In fact, several studies suggest that controlled cell
death enhances biofilm development by releasing nutrients and several vital constituents
for the biofilm extracellular polymeric matrix, such as proteins, carbohydrates, and
extracellular DNA (eDNA) (9, 22, 35, 38). The released eDNA, in particular, has been
shown to function as an adherence molecule in the biofilm matrix and to facilitate
horizontal gene transfer and antibiotic resistance (25). In this way, the controlled
autolysis of a small subpopulation of the colony will benefit the entire S. aureus biofilm,
thus aiding its survival against environmental stressors. However, this system requires
careful management to prevent unbridled autolysis and its subsequent adverse effects on
the colony (27). In several recent studies, this utilization of bacterial cell death to benefit
the production of biofilms has been shown to share many hallmark characteristics of
eukaryotic programmed cell death (PCD), or apoptosis. For example, controlled cell
death in S. aureus was found to display an increase in respiratory dysfunction, DNA
fragmentation, and production of reactive oxygen species (ROS) (35). Similar to
eukaryotic PCD or apoptosis, this process in S. aureus relies on the balance between
autolysis and cell division within the biofilm, which is maintained by several genetic
regulators and elaborate signaling pathways (9, 25, 26, 27, 35).
The operons cidABC, lrgAB, and alsSD are important in regulating autolysis (9,
38). The proteins CidA, a product of the cidABC operon, and LrgA, a product of the
lrgAB operon, have been demonstrated by studies to participate in bacterial PCD through
a holin-antiholin system (Fig. 3) (15, 38). It is suggested that CidA proteins fuse, forming
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oligomers and pores in the cytoplasmic membrane (38). As a consequence, the membrane
becomes depolarized, thus activating murein hydrolase activity and, ultimately, lysis and
death of the cells (38). In direct contrast, the LrgA protein is proposed to act as an
antiholin, which directly impedes the functioning of CidA (38). In this way, LrgA
prevents the membrane depolarization and subsequent autolysis of the cells (38).

Figure 3. Proposed regulatory network of cidABC and lrgAB operons. During
glucose catabolism, the enzymes PTS (phosphoenolpyruvate-dependent
phosphotransferase system), PDH (pyruvate dehydrogenase complex), PTA
(phosphotransacetylase) and AckA (acetate kinase) convert glucose to acetate. The genes
lrgA and cidA encode proteins that migrate to the cytoplasmic membrane to function as
antiholins and holins, respectively. The cidC gene encodes the enzyme CidC (pyruvate
oxidase) that converts pyruvate to acetate during overflow metabolism (25).

Furthermore, studies have found that the enzymes CidC (pyruvate oxidase) and
AlsSD (-acetolactate synthase/decarboxylase) antithetically control the levels of the
weak acid byproduct of carbon-overflow metabolism, acetate, which has been
13

demonstrated to mediate staphylococcal autolysis during stationary phase growth and
biofilm development (35, 38). This complex link between carbon-overflow metabolism
and autolysis is discussed in further detail.

Role of carbon-overflow metabolism in autolysis and biofilm formation.
During glucose catabolism, the process of glycolysis is primarily utilized in S.
aureus, producing two molecules of pyruvate, two net molecules of ATP, and two
molecules of NADH for every molecule of glucose. In aerobic conditions, pyruvate is
then converted to acetyl-coenzyme A (Acetyl-CoA) by the pyruvate dehydrogenase
(PDH) complex, releasing one molecule of CO2 and one molecule of NADH as
byproducts (26, 35). Acetyl-CoA can then be shunted into the tricarboxylic acid (TCA)
cycle or it can be converted to acetate by enzymes phosphotransacetylase (PTA) and
acetate kinase (AckA) (26). When S. aureus is grown in excess glucose and oxygen, it
undergoes overflow metabolism; CcpA-mediated catabolite repression limits the use of
the TCA cycle and instead shunts the Acetyl-CoA primarily into the Pta-AckA pathway
(35). As a result, acetate is produced by the S. aureus cells and accumulates in the
surrounding culture medium (26). This buildup of acetate causes the pH of the
extracellular environment to decrease, initiating the complicated process of cell death by
cytoplasmic acidification. As the pH outside of the cells approaches and eventually
becomes lower than the pKa of acetate (~4.8), the unprotonated acetate, which is
negatively charged, is protonated and forms acetic acid, which carries no charge. Because
acetic acid is neutral, it can diffuse freely across the cellular membrane and enter the
cytoplasm. Inside the cytoplasm, acetic acid is deprotonated and converts back to acetate,
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decreasing the intracellular pH. This cytoplasmic acidification gradually causes cellular
damage and cell death (38).
Although acetate is produced as a byproduct primarily by the
phosphotransacetylase-acetate kinase (Pta-AckA) pathway, this metabolic pathway has
been indicated to have no involvement in autolysis and biofilm formation (25, 26).
Studies seeking to investigate the relationship between acetate and autolysis have
recently shifted their focus to the cidABC and alsSD operons, which have been shown to
modulate levels of acetate in overflow glucose metabolism during biofilm development
(35). As discussed previously, the pyruvate oxidase (CidC) enzyme utilized by the CidC
pathway directly converts pyruvate to acetate and carbon dioxide. CidB has been
indicated to be a necessary component for the activation of this pathway. CidA and
AlsSD, on the other hand, oppose the functions of CidB and CidC and shunt the carbon
flow towards acetoin production rather than acetate production (Fig. 4). The transcription
of CidA and AlsSD is activated by a LysR-type regulator, called CidR, during conditions
of excess glucose (9). CidA represses the function of CidC, while the AlsSD pathway
utilizes the -acetolactate synthase/decarboxylase (AlsSD) enzyme to consume protons,
maintain intracellular pH, and to generate acetoin from the substrate pyruvate (9). In
summary, the enzymatic activities of both CidC and AlsSD inversely control the levels of
acetic acid produced by staphylococcal cells during carbon overflow metabolism and,
therefore, contribute to the balanced regulation of cell death during S. aureus biofilm
development (35).
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Figure 4. Regulatory role of CidR in production of acetate and mechanism of cell
death. This scheme shows the expression of the cidABC and the alsSD operons during
overflow metabolism. Following upregulation by B, CidB fully activates CidC, which is
responsible for producing acetate. This buildup of acetate eventually leads to cytoplasmic
acidification and ultimate cell death in the stationary phase. In the post-exponential
phase, cells upregulate CidR, a LysR-type transcription regulator. CidR helps oppose
cytoplasmic acidification and decrease the rate of cell death by activating CidA and
AlsSD. CidA suppresses the enzymatic activity of CidC. AlsSD helps maintain the
intracellular pH by consuming protons. Although not shown here, AlsSD also shifts
carbon flux away from CidC, thus reducing the amount of acetate produced (9).

Introduction to the msaABCR operon.
In previous works, msaABCR was identified as a four-gene operon that is
conserved in all strains of S. aureus (27, 28, 30); it codes for three functional noncoding
RNAs (msaA, msaC, and msaR) that help regulate the expression of msaB, the only
transcript of the entire operon that encodes a protein (27, 28, 30). Based on the results
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thus far, the MsaB protein acts as a transcription factor (4, 28). The operon msaABCR has
also been indicated in multiple studies to be involved in the expression of operons agr
and sarA (5, 27, 28, 29, 30). As previously discussed, these global regulators are essential
for the coordinated and controlled release of virulence factors (5, 27, 28, 29, 30) as well
as the production of biofilm (5, 27, 28, 29). Furthermore, msaABCR has been indicated to
function in the regulation of resistance to antimicrobial drugs, such as vancomycin (30).
Currently, the msaABCR operon is understood to regulate biofilm development,
virulence, and antibiotic resistance in response to environmental stimuli and host factors
(Fig. 5).

Figure 5. Proposed regulatory role of msaABCR operon. The operon msaABCR has
been indicated to control biofilm development, virulence, and antibiotic resistance in
response to host factors and environmental stimuli (4).
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Early studies have shown that the deletion of this msaABCR operon in S. aureus
cells results in a significant decrease in biofilm thickness and a significant increase in cell
death relative to the wild-type (WT) (28, 29) (Figs. 6 and 7).

USA300 LAC WT

msaABCR mutant

Complement msaABCR
Figure 6. Confocal laser scanning microscopy (CLSM) images of biofilm. After 48 h
of growth, biofilm was stained with Syto-9 and Toto-3 dyes, which stain the live cells
green and dead cells red, respectively (29). A significant decrease in live cells and
increase dead cells are shown in the msaABCR mutant relative to USA300 LAC WT.
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Figure 7. CLSM image analysis of biofilm. Three individual experiments of
COMSTAT image analysis were performed to obtain these values (%) for live cell and
dead cell biomass, and for average thickness of biofilm (m). The scale bars represent 10
m (29).

In addition, the results of a Triton X-100-induced autolysis assay during
planktonic growth showed that the msaABCR mutant was lysed at approximately 20-25%
higher rate compared to WT (29). Notably, it was suggested that this observed biofilm
defect in the msaABCR mutant could be a result of uncontrolled cell death (27). This
connection between bacterial cell death and biofilm production is an interesting
relationship that warrants extended study.
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Hypothesis and aims of study.
Research findings thus far have begun to describe the complex regulatory system
of controlled cell death during S. aureus biofilm formation. However, further study is
required to more thoroughly understand this regulatory system and discern the mediating
role of the weak acid byproduct of glucose metabolism, acetate. Studies from our lab
have demonstrated that the msaABCR operon regulates antibiotic resistance, production
and release of virulence factors, and biofilm formation in S. aureus (5, 28, 29, 30, 31, 32).
Furthermore, the deletion of the msaABCR operon in recent studies has resulted in an
increase in uncontrolled cell death and the production of a defective biofilm (29). While
it was suggested that uncontrolled autolysis may be the cause of the observed biofilm
defect in the msaABCR mutant, the precise mechanism is still largely unknown.
Based on these recent research findings, I hypothesized that the biofilm defect in
the msaABCR mutant is caused by a failure in the regulation of cell death due to the
accumulation of unutilized acetate and subsequent cytoplasmic acidification of S. aureus
cells. Past studies have shown that the microenvironment within the biofilm as seen under
flow cell conditions can be successfully simulated during planktonic growth by adding
excess glucose (35 mM) to the media (9, 35). Thus, the goals of this study were to assess
cell viability, biofilm formation, and acetate production of the msaABCR mutant grown in
conditions of excess glucose. Additionally, since it is known that low amounts of
antibiotics induce biofilm formation in S. aureus strains by inducing autolysis (14, 15, 16,
17, 23, 30), I added vancomycin to examine the role of the msaABCR operon in
antibiotic-induced biofilm formation. Findings from this research will provide more
information on how the msaABCR operon regulates biofilm formation, specifically in
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regard to programmed cell death. This study may assist future researchers and lead to the
development of novel therapeutic treatments against S. aureus infections.
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Chapter III: Materials and Methods
Bacterial strains and growth conditions.
In this study, the USA300 LAC and UAMS-1 strains were used, which are both
clinically relevant S. aureus strains. USA300 LAC is a community-acquired, methicillinresistant S. aureus (CA-MRSA) strain that has been shown to be markedly more virulent
than other strains and is frequently associated with chronic and severe infections (4).
UAMS-1 is a methicillin-resistant S. aureus (MRSA) strain that is a known osteomyelitis
isolate (5, 6).
To create the msaABCR deletion mutant, the same allelic gene replacement
method outlined in a previous study (28) was followed using the pKOR1 plasmid.
Endpoint PCR was performed to affirm that the in-frame deletion of the msaABCR
operon was successful. In order to construct the complementation plasmid, a copy of the
msaABCR operon from WT was amplified with the native promotor. This segment, of
approximately 1788 bp with untranslated regions at the 5’ and 3’ ends, was then fused to
the shuttle vector, pCN34. Finally, the complementation plasmid construct was inserted
back into the msaABCR deletion mutant via electroporation and transduction. Overnight
cultures of WT strains and their respective msaABCR deletion mutant and complement
strains were prepared. To prepare the overnight cultures, small amounts of frozen stock
of each strain were inoculated in 5mL of Bacto™ Tryptic Soy Broth (TSB). These
cultures were then incubated overnight at 37 C with shaking (220 rpm).

Media preparation.
According to instructions by the manufacturers, Bacto™ Tryptic Soy Broth (TSB)
and Bacto™ Tryptic Soy Agar (TSA) were prepared by mixing the appropriate volumes
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of distilled water and amounts of powdered media. Biofilm media was prepared by
mixing TSB with 3% NaCl and 0.25% glucose. The bottles of media were then sterilized
by autoclaving before use.

Bacterial growth normalization of liquid cultures.
To ensure that the starting cultures for all performed assays had equal amounts of
bacterial cell growth, a spectrophotometer was used to measure the optical densities of
the cultures at 600 nm. To prepare the starting culture, overnight cultures were diluted 10
times and grown for another 2 h. Then, each of the 2 h grown cultures were used as an
original culture to normalize to OD600 in the required volume for each assay. The volume
of original overnight culture to resuspend in the required volume for each assay was
calculated by (1) multiplying the desired bacterial cell density (OD600 of 0.05) and the
volume of the fresh media prepared for resuspension, (2) dividing by the OD600
measurement of the original culture, and finally, (3) multiplying by 1,000 μL. These
calculations can be condensed into the following equation:
𝑽𝒐𝒍𝒖𝒎𝒆 (𝛍𝐋) 𝒐𝒇 𝒐𝒓𝒊𝒈𝒊𝒏𝒂𝒍 𝒄𝒖𝒍𝒕𝒖𝒓𝒆 𝒕𝒐 𝒓𝒆𝒔𝒖𝒔𝒑𝒆𝒏𝒅 𝒊𝒏 𝒇𝒓𝒆𝒔𝒉 𝒎𝒆𝒅𝒊𝒂 =
[𝐷𝑒𝑠𝑖𝑟𝑒𝑑 𝑏𝑎𝑐𝑡𝑒𝑟𝑖𝑎𝑙 𝑐𝑒𝑙𝑙 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 (𝑂𝐷) × 𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑝𝑟𝑒𝑝𝑎𝑟𝑒𝑑 𝑚𝑒𝑑𝑖𝑎 (𝑚𝐿)]
× 1000 μL
𝑂𝐷 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑚𝑒𝑛𝑡

Biofilm assays.
To perform the biofilm assays, the original protocol outlined by
Sambanthamoorthy et al. was followed with modifications added by Sahukhal & Elasri
(28, 31). Each well of the microtiter plates was first pre-coated with 20% human plasma
and then incubated the plates overnight at 4C. Next, each well was inoculated with 2 mL
of starter culture prepared as mentioned in the “Bacterial growth normalization of liquid
cultures” section. The biofilm media prepared for this assay was made by mixing TSB
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with 3% NaCl and 0.25% glucose. For the excess glucose conditions, an additional 0.5 %
glucose was added to the appropriate wells. Vancomycin (0.2 g/mL) and
morpholinepropanesulfonic acid (MOPS) buffer (50 mM; pH 7.3) were also added, when
necessary. The microtiter plates were then incubated at 37 C for 24 to 48 h with shaking
at 150 rpm. After 24 h, each well was washed with sterile phosphate-buffered saline
(PBS), and the resulting biofilms were stained with crystal violet dye and eluted with 5%
acetic acid. To measure the amount of biofilm, a spectrophotometer was used to
quantitate at 595 nm. The assays were performed in experimental duplicates for USA300
LAC WT, msaABCR mutant and complement strains. The biofilm assays were performed
three times. Biofilm formation values were calculated as the percent activity relative to
USA300 LAC WT, which was set as 100%. Next, the mean values and standard
deviations of each growth condition were calculated.

Cell death assays.
To determine the effects of excess glucose on cell death, the survival of different
strains was monitored for 5 days. WT, msaABCR mutant, and complement strains of both
USA300 LAC and UAMS-1 were grown aerobically in tryptic soy broth (TSB) with
excess glucose (35 mM glucose) and, when necessary, supplemented with
morpholinepropanesulfonic acid (MOPS) buffer (50 mM; pH 7.3). Cultures were
incubated for 120 h at 37 C with shaking at 220 rpm. Colony-forming units (CFUs) were
counted at every 24-hour interval after plating. For CFU counting, cultures were serially
diluted up to the appropriate dilutions and 100L were plated in TSA plates. The TSA
plates were then incubated at 37C. To verify the consistency of these results, the cell
death assays for each sample were performed in triplicate and repeated at least three
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times. The colony-forming units from each sample were averaged to obtain the mean
values, and the standard deviation was calculated.

Measurement of acetate production.
Cultures of USA300 LAC WT, msaABCR deletion mutant, and complementation
strains were grown in TSB supplemented with 35mM glucose and incubated at 37 C
with shaking at 250 rpm. Supernatants from the cultures were collected after 6 h and
OD600 was recorded. The amount of acetate production was measured using the RBiopharm acetate determination commercial kit according to instructions by the
manufacturer. Rate of acetate production was calculated as acetate concentration
produced (mM)/OD/time (h), as shown below:
𝑹𝒂𝒕𝒆 𝒐𝒇 𝒂𝒄𝒆𝒕𝒂𝒕𝒆 𝒑𝒓𝒐𝒅𝒖𝒄𝒕𝒊𝒐𝒏 =
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑎𝑐𝑒𝑡𝑎𝑡𝑒 𝑝𝑟𝑜𝑑𝑢𝑐𝑒𝑑 (𝑚𝑀) ÷ 𝑂𝐷 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑚𝑒𝑛𝑡 ÷ 𝑇𝑖𝑚𝑒 (ℎ𝑟)

Data analysis.
The data collected from this study were statistically analyzed with OriginPro
software (Origin Lab, Northampton, MA). Values of P  0.05 were considered
significant. WT results were compared to the msaABCR deletion mutant results using
both t-tests and one-way analyses of variance (ANOVA).
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Chapter IV: Results
Excess glucose and vancomycin cannot induce biofilm formation in the
msaABCR deletion mutant.
As expected, biofilm production increased significantly in USA300 LAC WT
strain after the addition of excess glucose (Fig. 8). This increase in biofilm production
was further augmented by the addition of vancomycin. However, this increase in biofilm
production after the addition of glucose and vancomycin was not observed for the
msaABCR deletion mutant of USA300 LAC (Fig. 8). Unlike with WT, the environmental
stressors excess glucose and vancomycin were not able to induce biofilm formation in the
msaABCR deletion mutant.
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***

***
***

Figure 8. Biofilm formation of USA300 LAC wild-type, msaABCR deletion mutant,
and complementation strains. Measured biofilm formation for normal conditions,
excess glucose conditions, and excess glucose conditions with added vancomycin. The
error bars represent the standard deviation (STDEV). Results of WT were compared to
the corresponding mutants with t test and one-way ANOVA: P < 0.001 is highly
significant results (***); 0.01  P < 0.001 is very significant results (**); 0.05  P < 0.01
is significant results (*).

The msaABCR operon represses unregulated cell death in biofilm condition.
As shown by the stationary phase survival results, the survival of the msaABCR
mutant was slightly decreased relative to that of the USA300 LAC WT when grown in
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only 14mM glucose (Fig. 9). However, when grown in excess glucose conditions (35mM
glucose), a steep decline in cell viability of the msaABCR mutant was observed compared
to that of the USA300 LAC WT (Fig. 10).

*
***

Figure 9. Stationary phase survival of USA300 LAC without excess glucose. Cell
viability (CFU/mL) of USA300 LAC wild-type, msaABCR mutant, and complement
strains grown in TSB with 14 mM glucose was assessed over 5 days. The error bars
represent the standard deviation (STDEV). Results of WT were compared to the
corresponding mutants with t test and one-way ANOVA: P < 0.001 is extremely
significant results (***); 0.01  P < 0.001 is very significant results (**); 0.05  P < 0.01
is significant results (*).
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***
**
*

**

**
Figure 10. Stationary phase survival of USA300 LAC with excess glucose. Cell
viability (CFU/mL) of USA300 LAC wild-type, msaABCR mutant, and complement
strains grown in TSB with 35 mM glucose was assessed over 5 days. The error bars
represent the standard deviation (STDEV). Results of WT were compared to the
corresponding mutants with t test and one-way ANOVA: P < 0.001 is extremely
significant results (***); 0.01  P < 0.001 is very significant results (**); 0.05  P < 0.01
is significant results (*).

Similar results were observed for the stationary phase survival of the UAMS-1
strain. There was a significant drop in survival observed for the msaABCR mutant strain
when grown with excess glucose (35 mM glucose) (Fig. 11). Together, these results
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suggest that the increase of autolysis observed in the msaABCR mutant strain relies on
cellular acidification.

***
***

***

**

Figure 11. Stationary phase survival of UAMS-1 with excess glucose. Cell viability
(CFU/mL) of UAMS-1 wild-type, msaABCR mutant, and complement strains grown in
TSB with 35 mM glucose was assessed over 5 days. The error bars represent the standard
deviation (STDEV). Results of WT were compared to the corresponding mutants with t
test and one-way ANOVA: P < 0.001 is extremely significant results (***); 0.01  P <
0.001 is very significant results (**); 0.05  P < 0.01 is significant results (*).

Deletion of the msaABCR operon causes an increase in acetate production.
During the early stationary growth phase after 6 h, the msaABCR deletion mutant
produced more acetate at a higher rate compared to wild-type in early stationary phase
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(Fig. 12). This result suggests that the msaABCR operon is involved in the regulation of
carbon overflow metabolism and the production of acetate.

Figure 12. Acetate production in USA300 LAC, msaABCR deletion mutant and
complementation. Cultures of USA300 LAC wild-type, msaABCR deletion mutant, and
complementation strains were grown in TSB supplemented with 35mM glucose and
incubated at 37 C with shaking at 250 rpm. Supernatants from the cultures were
collected after 6 h and OD was recorded. Then, the amount of acetate production was
measured using the R-Biopharm acetate determination commercial kit according to
instructions by the manufacturer. Rate of acetate production was calculated as acetate
concentration produced (mM)/OD/time (h).
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Increased cell death in the msaABCR deletion mutant is due to weak acid
intracellular acidification.
To assess if the observed decrease in cell viability of the msaABCR mutant strains
grown with excess glucose was indeed caused by intracellular acidification, the cell death
assay was repeated using both strains supplemented with excess glucose (35 mM
glucose) and 50 mM morpholinepropanesulfonic acid (MOPS). The MOPS buffer
maintains the pH of the growth medium at approximately 7.3-7.4, thus preventing the
medium from becoming acidic. In accordance with our hypothesis, the cell viability of
the msaABCR mutant strains buffered with MOPS significantly increased, reverting to
similar survival values as the USA300 LAC WT strain (Fig. 13). This observation was
consistent in the repeated experiment using the UAMS-1 strain as well (Fig. 14).
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***
*

Figure 13. Stationary phase survival of USA300 LAC grown in excess glucose
conditions with added MOPS buffer. Cell viability (CFUs/mL) of USA300 LAC WT,
msaABCR mutant, and complement strains grown in TSB with 35mM glucose with added
50 mM MOPS buffer (7.3 pH). The error bars represent the standard deviation (STDEV).
Results of WT were compared to the corresponding mutants with t test and one-way
ANOVA: P < 0.001 is extremely significant results (***); 0.01  P < 0.001 is very
significant results (**); 0.05  P < 0.01 is significant results (*).
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***
***

***
***

Figure 14. Stationary phase survival of UAMS-1 grown in excess glucose conditions
with added MOPS buffer. Cell viability (CFUs/mL) of UAMS-1 WT, msaABCR
mutant, and complement strains grown in TSB with 35mM glucose with added 50 mM
MOPS buffer (7.3 pH). The error bars represent the standard deviation (STDEV). Results
of WT were compared to the corresponding mutants with t test and one-way ANOVA: P
< 0.001 is extremely significant results (***); 0.01  P < 0.001 is very significant results
(**); 0.05  P < 0.01 is significant results (*).

Due to the significant increase in cell survival observed after the addition of
MOPS buffer, I also investigated the effect of MOPS buffer on glucose-induced biofilm
formation in USA300 LAC WT, msaABCR, and complementation strains. Biofilm assays
were performed with conditions of excess glucose as well as excess glucose and MOPS
buffer. The addition of MOPS to the msaABCR mutant resulted in an increase in biofilm
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formation (Fig. 15), thus further indicating that the increase in cell death observed with
the msaABCR mutant grown in excess glucose is caused by intracellular acidification.
CLSM images of the msaABCR mutant + 35mM glucose + MOPS biofilm (not included
in this thesis) revealed that, while production was increased, the biofilm produced was
defective and not well attached.

***

***
Figure 15. Biofilm formation of USA300 LAC with addition of excess glucose and
MOPS buffer. Measured biofilm formation of USA300 LAC WT, msaABCR deletion
mutant, and complementation strains grown in normal conditions, excess glucose
conditions, and excess glucose conditions with added MOPS buffer. The error bars
represent the standard deviation (STDEV). Results of WT were compared to the
corresponding mutants with t test and one-way ANOVA: P < 0.001 is extremely
significant results (***); 0.01  P < 0.001 is very significant results (**); 0.05  P < 0.01
is significant results (*).
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Chapter V: Discussion
The ability of S. aureus to cause chronic, antibiotic-resistant infections is largely
attributed to its production of multilayered biofilms (2, 9, 11, 24, 27, 29, 31, 33). A
recently identified global regulator of sarA, the msaABCR operon, has been shown to
influence virulence factor regulation, antibiotic resistance, and biofilm formation (5, 27,
28, 29, 30). Previously, Sahukhal et al. (29) demonstrated that the deletion of the
msaABCR operon results in the production of a defective biofilm relative to the wildtype, with significantly decreased live cell biomass and average biofilm thickness (28,
29). However, the precise mechanism behind these results was not yet understood. In this
study, I aimed to elucidate the role of the msaABCR operon during biofilm formation.
Given that excess glucose and sub-MIC antibiotics are known to induce biofilm
formation (14, 17, 23, 30), biofilm assays were performed with TSB supplemented with
excess glucose (35mM glucose) and excess glucose with vancomycin (0.2 g/mL).
Corresponding to the results from Sahukhal et al. (29), the msaABCR deletion mutant of
USA300 LAC had a significant decrease in biofilm formation (Fig. 8). Furthermore, this
study showed a significant increase in biofilm production in wild-type USA300 LAC
(Fig. 8) with the addition of excess glucose. As expected, biofilm formation of both wildtype strains was further induced with the addition of vancomycin. In contrast, the
addition of excess glucose and vancomycin was not able to induce biofilm formation in
the msaABCR deletion mutant of USA300 LAC, indicating that the msaABCR operon
plays a role in antibiotic- and glucose-induced biofilm formation.
The process of cell death is necessary for adequate biofilm formation, as it
releases the necessary constituents for the extracellular matrix, such as eDNA (25, 35,
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39). However, the homeostatic balance between the dying and growing cells must be
maintained for proper biofilm development (9, 25, 26, 27, 35). To better understand the
mechanism of msaABCR operon regulation of biofilm formation and investigate its role
in controlled cell death, I measured the stationary phase survival of USA300 LAC and
UAMS-1 strains grown in TSB and TSB with excess glucose. The stationary phase
survival of the USA300 LAC msaABCR mutant decreased slightly when the bacteria
were grown in 14 mM glucose (Fig. 9), but it exhibited a significant drop during growth
in excess glucose (Fig. 10). These results were also observed in the UAMS-1 strain
stationary phase survival assay (Fig. 11). This dramatic rate of autolysis shown in the
msaABCR deletion mutant grown in excess glucose has significant effects on biofilm
production; an unproportionate number of dying cells inhibits biofilm production.
Supporting this result, another study conducted by Boles et al. has also shown that
altering the rates of autolysis in S. aureus strains that use ica-independent biofilm
formation mechanisms results in the formation of a defective biofilm (7). Moreover,
because the significant decrease in cell survival of the msaABCR mutant was only present
when grown in 35mM glucose, these results suggest that acidification is required for
controlled cell death to occur. This has also been demonstrated in a previous study
conducted by Windham et al., which used a similar survival assay (38). After comparing
the survival of wild-type and their srrAB deletion mutant grown in TSB and TSB with
excess glucose (35mM), Windham et al. reported that the viability of the srrAB deletion
mutant was similar to that of the wild-type when grown in 14mM glucose (38). When
grown in excess glucose (35mM), the srrAB deletion mutant showed a significant
decrease in survival in relation to the wild-type (38). Overall, the survival assay results

37

suggest that the defective biofilm formed by the msaABCR mutant is a result of an
uncontrolled, dramatic increase in cell death, thus supporting my hypothesis. Indeed, the
results of this study indicate that the msaABCR operon is important for regulating weak
acid-dependent cell death in S. aureus cells.
In S. aureus, controlled cell death during biofilm formation has been shown to be
mediated by acetate, a weak acid byproduct of carbon overflow metabolism (9, 25, 35,
38). When grown in excess glucose, S. aureus undergoes carbon overflow metabolism,
producing acetate as a byproduct. The accumulation of acetate ultimately causes
intracellular acidification and cell death in S. aureus (38). In correspondence with past
studies, our results show that the msaABCR deletion mutant exhibits increased production
of acetate in relation to wild-type. Furthermore, when grown in TSB supplemented with
excess glucose and MOPS buffer to maintain a neutral pH, the msaABCR deletion mutant
no longer shows a significantly lower cell survival compared to wild-type in both
USA300 LAC and UAMS-1 strains. The results from the biofilm assays of USA300 LAC
WT, msaABCR mutant, and complement grown in conditions of excess glucose and of
excess glucose with added MOPS buffer agreed with the cell death assay results. When
MOPS buffer was added, the biofilm production of the msaABCR mutant increased.
These results suggest that intracellular acidification is responsible for the increased cell
death observed in the msaABCR mutant grown in excess glucose conditions. Although
the addition of MOPS resulted in an increase in biofilm production in the msaABCR
mutant grown in excess glucose, it is important to also note the quality of the biofilm.
CLSM images (not included in this thesis) revealed that the biofilms produced by the
msaABCR mutant as well as wild-type strains grown in excess glucose and MOPS were
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defective, and they were not capable of sufficient attachment. Thus, these results
demonstrate that the increased cell death resulting from the deletion of the msaABCR
operon is caused by increased production of acetate and subsequent intracellular
acidification.
In conclusion, this study suggests that the msaABCR operon may be involved in
biofilm formation through the process of acid-dependent controlled cell death in S.
aureus. The deletion of the msaABCR operon caused a significant increase in
uncontrolled cell death resulting from an increase in the production of acetate and
intracellular acidification. These results help further elucidate the regulatory role of the
msaABCR operon during biofilm development. The relationship between the msaABCR
operon and biofilm development of S. aureus is promising and warrants continued study.
This project and other similar research may lead to the identification of new therapeutic
targets for improved treatment efficacy and prevention of S. aureus biofilm development.
In future studies, we plan to explore the physiological status of the dying population of
wild-type and msaABCR mutant cells using flow cytometry. While comparing this cell
death mechanism in S. aureus to the well-studied eukaryotic PCD, it would also be
advantageous to measure the production of reactive oxygen species (ROS). As the
operons cidABC, lrgAB, and alsSD are known to play major roles in the regulation of
PCD pathways, there are also plans to perform real-time quantitative reverse transcription
PCR (QRT-PCR) of the following genes: LrgA, LrgB, CidA, CidB, CidC, CidR, AlsS, and
AlsD Continued research is crucial for understanding how S. aureus creates chronic
infection and for developing future alternative treatments to combat the current rise in
highly virulent, antibiotic-resistant strains in clinical and community settings.
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